Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro

As a global health problem, liver fibrosis still does not have approved treatment. It was proved that N-(3,4,5-trichlorophenyl)-2(3-nitrobenzenesulfonamide) benzamide (IMB16-4) has anti-hepatic fibrosis activity. However, IMB16-4 displays poor water solubility and poor bioavailability. We are devote...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Xia, Meng, Yanan, Wang, Yucheng, Li, Guiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230879/
https://www.ncbi.nlm.nih.gov/pubmed/35744862
http://dx.doi.org/10.3390/molecules27123738
_version_ 1784735182695170048
author Niu, Xia
Meng, Yanan
Wang, Yucheng
Li, Guiling
author_facet Niu, Xia
Meng, Yanan
Wang, Yucheng
Li, Guiling
author_sort Niu, Xia
collection PubMed
description As a global health problem, liver fibrosis still does not have approved treatment. It was proved that N-(3,4,5-trichlorophenyl)-2(3-nitrobenzenesulfonamide) benzamide (IMB16-4) has anti-hepatic fibrosis activity. However, IMB16-4 displays poor water solubility and poor bioavailability. We are devoted to developing biodegraded liposome-coated polymeric nanoparticles (LNPs) as IMB16-4 delivery systems for improving aqueous solubility, cellular uptake, and anti-fibrotic effects. The physical states of IMB16-4−LNPs were analyzed using a transmission electron microscope (TEM), high-performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and differential scanning calorimeter (DSC). The results show that IMB16-4−LNPs increased the drug loading compared to liposomes and enhanced cellular uptake behavior compared with IMB16-4−NPs. In addition, IMB16-4−LNPs could repress the expression of hepatic fibrogenesis-associated proteins, indicating that IMB16-4−LNPs exhibited evident anti-fibrotic effects.
format Online
Article
Text
id pubmed-9230879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92308792022-06-25 Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro Niu, Xia Meng, Yanan Wang, Yucheng Li, Guiling Molecules Article As a global health problem, liver fibrosis still does not have approved treatment. It was proved that N-(3,4,5-trichlorophenyl)-2(3-nitrobenzenesulfonamide) benzamide (IMB16-4) has anti-hepatic fibrosis activity. However, IMB16-4 displays poor water solubility and poor bioavailability. We are devoted to developing biodegraded liposome-coated polymeric nanoparticles (LNPs) as IMB16-4 delivery systems for improving aqueous solubility, cellular uptake, and anti-fibrotic effects. The physical states of IMB16-4−LNPs were analyzed using a transmission electron microscope (TEM), high-performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and differential scanning calorimeter (DSC). The results show that IMB16-4−LNPs increased the drug loading compared to liposomes and enhanced cellular uptake behavior compared with IMB16-4−NPs. In addition, IMB16-4−LNPs could repress the expression of hepatic fibrogenesis-associated proteins, indicating that IMB16-4−LNPs exhibited evident anti-fibrotic effects. MDPI 2022-06-10 /pmc/articles/PMC9230879/ /pubmed/35744862 http://dx.doi.org/10.3390/molecules27123738 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Niu, Xia
Meng, Yanan
Wang, Yucheng
Li, Guiling
Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title_full Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title_fullStr Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title_full_unstemmed Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title_short Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro
title_sort established liposome-coated imb16-4 polymeric nanoparticles (lnps) for increasing cellular uptake and anti-fibrotic effects in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230879/
https://www.ncbi.nlm.nih.gov/pubmed/35744862
http://dx.doi.org/10.3390/molecules27123738
work_keys_str_mv AT niuxia establishedliposomecoatedimb164polymericnanoparticleslnpsforincreasingcellularuptakeandantifibroticeffectsinvitro
AT mengyanan establishedliposomecoatedimb164polymericnanoparticleslnpsforincreasingcellularuptakeandantifibroticeffectsinvitro
AT wangyucheng establishedliposomecoatedimb164polymericnanoparticleslnpsforincreasingcellularuptakeandantifibroticeffectsinvitro
AT liguiling establishedliposomecoatedimb164polymericnanoparticleslnpsforincreasingcellularuptakeandantifibroticeffectsinvitro

Ejemplares similares